Lee, E. K., Tan-Wasielewski, Z., Matulonis, U. A., Birrer, M. J., Wright, A. A., Horowitz, N., . . . Liu, J. F. (2019). Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer. Gynecol Oncol Rep.
Styl ChicagoLee, Elizabeth K., Zhenying Tan-Wasielewski, Ursula A. Matulonis, Michael J. Birrer, Alexi A. Wright, Neil Horowitz, Panagiotis A. Konstantinopoulos, Jennifer Curtis, a Joyce F. Liu. "Results of an Abbreviated Phase Ib Study of the HDAC6 Inhibitor Ricolinostat and Paclitaxel in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer." Gynecol Oncol Rep 2019.
Citace podle MLALee, Elizabeth K., et al. "Results of an Abbreviated Phase Ib Study of the HDAC6 Inhibitor Ricolinostat and Paclitaxel in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer." Gynecol Oncol Rep 2019.